250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotech Angel Investors in United Kingdom

A list of 50 angel investors that invest in Biotech startups based in United kingdom. We rank investors based on the number of investments they made in Biotech companies from United kingdom. We update this investor list every month.

Top 50 Biotech Angel Investors in United Kingdom

Investor Biotech United Kingdom investments
Jonathan Milner 24
Nadav Rosenberg 5
Stefano Bernardi 3
Peder Nielsen 3
Darrin Disley 3
DrPano Kroko Churchill 3
Jude Gomila 3
Milad Alucozai 3
Charlie Songhurst 3
Ian Hogarth 3
Serge Chiaramonte 2
Gilad Engel 2
Mark Evans 2
Jan Hruska 2
Paul Wicks 2
Nick Boyle 2
Inaki Berenguer 2
Tim Dempsey 2
Edward Lando 2
Pratima Aiyagari 2
Ariel Poler 2
Jon Oringer 2
Patrick Pichette 2
Ed Parkinson 2
Nadav Ben-Chanoch 2
Bradley Horowitz 2
Jim Mellon 2
Jon Oringer 2
Chris Mairs 2
Hugh Grant 2
Nicholas Edwards 2
Paul Forster 2
Jon Oringer 2
Sarah Howell 1
Simon Galbraith 1
Sharaf Yamani 1
Aydın Öztunalı 1
Hugo Amsellem 1
David Rowan 1
Andrew J M Richards 1
Declan Doogan 1
Taz Patel 1
Jeff Dean 1
Sami Mikati 1
Ahmed Medhat 1
Silla Scheepens 1
Martin Chavez 1
Alice Zhang 1
Huw Bishop 1
Michelle Tempest 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Jonathan Milner Angel · Cambridge, Massachusetts, United States · 4 investments in the past 12 months
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United Kingdom, United States, Canada
Portfolio highlights
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — At PharmEnable Therapeutics we access the inaccessible. We are re-imagining small molecule therapeutics through AI.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Nadav Rosenberg Angel · London, England, United Kingdom
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Pharmaceutical
  • Seed, Pre-Seed, Series A
  • United Kingdom, Israel, Singapore
Portfolio highlights
  • thymia — Making mental health as objectively measurable as physical health.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.
Stefano Bernardi Angel · San Francisco, California, United States · 3 investments in the past 12 months
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more
Investment focus
  • Software, Biotechnology, Artificial Intelligence
  • Seed, Pre-Seed, Funding Round
  • Italy, France, Norway
Portfolio highlights
  • Freatic — We bridge the gap between individuals with untapped knowledge and actors who can take advantage of these opportunities.
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
Peder Nielsen Angel · Copenhagen, Hovedstaden, Denmark
Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund
Show more
Investment focus
  • Biotechnology, Machine Learning
  • Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Darrin Disley Angel · Cambridge, Cambridgeshire, United Kingdom
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more
Investment focus
  • Biotechnology, Health Care, Big Data
  • Seed, Series A, Funding Round
  • United Kingdom
Portfolio highlights
  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
DrPano Kroko Churchill Angel · Seattle, Washington, United States
Pano Kroko is a legendary entrepreneur, Angel, VC and PE investor in innovation towards solving big problems. His investment emphasis is on Life Sciences, Biotech, Therapeutics, Medicine, Internet, Mobile, Communications, Clean Technology, Renewable Energy, and Environmental Finance. We have a quarterly Business Plan competition for placementin our early stage start up accelerator in Seattle Washington. We also run a program in Washington DC, and we have an Innovation Master Class Startup Weekend that runs Ten times a year in Seattle, Beijing, Silicon Valley, and in major Universities around the world.The Accelerator in Seattle & Silicon Valley is called American Angels, and the Accelerator in Washington DC is named H2O and both accept business plans and great ideas with Founders, and Executive teams right now. We would like to see StartUps in all of our areas of focus as well as anything else that is great and promising to solve Big Problems. Parallel to this we also run the CEP - Clean Energy Program incubator in Oxford UK, and the Biotech accelerator for genetics, stem cell applications, genomics, medicine, pharma and telomeres research in Cambridge UK.For our more traditional VC and PE work in the US, the American Venture Company in the US and the Investment Bank Green Capital Inc in the UK and Europe. These are our conduits of support for companies and also the Green Bonds Investments Plc. All of our organizations act as levers of positive change for impact investing, and as corporate environmental investment responsibility -- within the Finance community.In Seattle and in Silicon Valley we run the Accelerator and Early Stage Investment firm AMERICAN ANGELS where we have monthly pitches and demos for new StartUps and we also run a CEO roundtable to help promising Entrepreneurial leaders to succeed.If you or your company is interested in cooperation, presenting, funding, deal syndication or simply for submission of Executive Summaries and Business Plans for early stage angel funding and/or inclusion in the H2O Incubator/Accelerator or the Clean Energy program and the Biotech incubator, please contact us herewith: Mr Ruddy Wallace: envpar [at] gmail.com
Show more
Investment focus
  • Health Care, Therapeutics, Biotechnology
  • Angel, Series A
  • United Kingdom
Portfolio highlights
  • Amrit Advanced Biotech — Company working in Genetics, Telomeres health applications, cancer mitigation and lengthening of....
Jude Gomila Angel · San Francisco, California, United States · 3 investments in the past 12 months
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Pre-Seed, Angel
  • United States, United Kingdom, Canada
Portfolio highlights
  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • HockeyStack — Connect your ads, website, and CRM, and turn your data into accurate customer journeys. Find out which content, channels, and efforts drive revenue and refine your strategy.
  • Gradia Health — Gradia is an integrated, concierge care platform designed for clinics to support patients with chronic conditions.
Milad Alucozai Angel · San Francisco, California, United States
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Charlie Songhurst Angel · Greater Seattle Area, Washington, United States · 16 investments in the past 12 months
Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Pre-Seed, Funding Round
  • United Kingdom, United States, Germany
Portfolio highlights
  • Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
  • StackOne — Accelerate your SaaS growth with our unified API solution for HRIS, ATS, and CRM. Say "yes" to customers, build advanced integrations quickly, and experienced the best data privacy controls in the market.
  • Utila — Utila is an enterprise-scale self-custody platform that manages your organization's crypto strategy with safe, chain-agnostic wallet infrastructure.
Ian Hogarth Angel · London, England, United Kingdom
Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.
Show more
Investment focus
  • Software, E-Commerce, Internet
  • Seed, Pre-Seed, Series A
  • United Kingdom, United States, Germany
Portfolio highlights
  • Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Fabric — A file explorer and workspace for the internet age. Your drives, clouds, notes, screenshots, links and files automatically gathered into one intelligent home. The world's first AI-native universal storage.
Serge Chiaramonte Angel · London, England, United Kingdom · 3 investments in the past 12 months
Serge Chiaramonte
Show more
Investment focus
  • FinTech, Financial Services, Information Technology
  • Seed, Pre-Seed, Funding Round
  • United Kingdom, United States, France
Portfolio highlights
  • Trezy — Trezy is smart & simple software the helps you manage your business with real-time finance insights & automated cash-flow forecasting.
  • qomodo — Qomodo is an "all-in-one" payment methods aggregator, allowing physical commercial operators to safeguard and expand their cash flow and offer Buy Now Pay Later payments to customers, in addition to one-time payments. Qomodo focuses on merchants providing services for essential yet often unforeseen expenses, which typically involve ahigher transaction value.
  • Borderless — Borderless is a workforce migration platform.It offers automation solutions that focuses on all aspects of hiring and onboarding of foreign workers, including recruitment, immigration, relocation, and compliance.
Gilad Engel Angel
Gilad Engel - Partner @ Target Global
Show more
Investment focus
  • Hardware, Analytics, Biotechnology
  • Seed, Pre-Seed
  • France, Israel, United Kingdom
Portfolio highlights
  • Joe — Joe is an financial service that reimburses and allows ALL expenses to be paid in several installments.
  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • Fourier Optics — Fourier's Metasurface optical combiner seamlessly embeds inside everyday glasses' lenses.
Mark Evans Angel · London, England, United Kingdom
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Funding Round, Series A, Seed
  • United Kingdom, United States, The Netherlands
Portfolio highlights
  • ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
  • Ufonia — Ufonia is replacing routine patient healthcare interactions with next-generation automated phone calls.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Jan Hruska Angel
Jan Hruska
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Paul Wicks Angel · London, England, United Kingdom
Paul is a neuropsychologist and expert in digital health, clinical trials, and patient centricity. For 13 years he led the R&D team at PatientsLikeMe, an online community for over 700,000 people living with medical conditions. Specialising in clinical research using the Internet, Paul shaped the scientific validity of the platform in generatinginsights from patient-generated health data, leading to over 110 studies including a patient-driven observational trial of lithium in ALS, numerous patient-reported outcome measures, a “dose-response” curve for the benefits of friendship between patients, and methods for patient-centered and virtual clinical trial designs.He sits on the editorial boards of the BMJ, BMC Medicine, JMIR, Digital Biomarkers and The Patient. Prior to joining PatientsLikeMe, Paul worked at the Institute of Psychiatry (King’s College London) studying cognition and neuroimaging in ALS, with a postdoc in psychological consequences of Parkinson’s disease.His work has been profiled by the BBC, NPR, CNN, BBC Radio 4, the Wall Street Journal, and the New York Times. In 2011 he was awarded MIT Technology Review’s TR35 “Humanitarian of the Year” award, recognized as a TED Fellow in 2012, and joined the inaugural FLIER Program at the Academy of Medical Sciences in 2019.
Show more
Investment focus
  • Real Time, Marketplace, Biotechnology
  • Seed, Series A
  • United Kingdom
Portfolio highlights
  • Sano Genetics — Sano Genetics is a user-centric genetic data marketplace that connects individuals directly to the research world. It act as ethical brokers to facilitate a direct connection between you and research institutions. The company was founded in 2017 and is headquartered in Cambridge.
Nick Boyle Angel · London, England, United Kingdom
In 2010, Nick founded Lightsource Renewable Energy, then just a six-person start-up, which quickly grew over 5 years to become Europe’s largest solar developer and operator and a recognised global leader. In his role as Group CEO, Nick’s dynamic leadership and vision has driven the company to tremendous success and in December 2017, Lightsourceannounced a strategic partnership with BP which has committed aggressively to accelerate the low carbon transition. The company has rebranded to Lightsource BP in affirmation of this powerhouse commitment which is set to shape the future of global energy delivery. Nick previously sat at Board and Senior Director level in a number of leading retail financial service companies. Throughout his career, Nick has always been recognised for his entrepreneurial skill and success in pairing retail financial products with low-risk, predictable investments.
Show more
Investment focus
  • Biofuel, Agriculture, Artificial Intelligence
  • Seed
  • United Kingdom
Portfolio highlights
  • Better Origin — At Better Origin, our mission is to fix the broken food chain by converting waste into high-value insect products.
  • Better Origin — At Better Origin, our mission is to fix the broken food chain by converting waste into high-value insect products.
Inaki Berenguer Angel · New York, New York, United States · 3 investments in the past 12 months
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more
Investment focus
  • E-Commerce, Software, FinTech
  • Seed, Angel, Pre-Seed
  • Spain, United States, United Kingdom
Portfolio highlights
  • Bankflip — Permissioned data technology to collect and process your customers' income, tax, employment & other relevant data & documents in real-time
  • Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
  • Mable (Neurolytic Healthcare) — Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.The company delivers digitally and genomically-drivenmedical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Tim Dempsey Angel
Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • United Kingdom
Portfolio highlights
  • Lunio — Drive performance marketing efficiency by cutting out invalid traffic across all paid marketing channels. Reach more users with the same ad spend.
  • Mitra bio — We are transforming skin-care by approaching ageing as a disease to be fought. We are developing a genetic and epigenetic discovery platform to help skincare companies find and develop new compounds that actually fight the root cause of skin ageing.
  • PPC Protect — Drive performance marketing efficiency by cutting out invalid traffic across all paid marketing channels. Reach more users with the same ad spend.
Edward Lando Angel · San Francisco, California, United States · 9 investments in the past 12 months
Edward Lando is the Founder of Pareto Holdings. He previously worked at Horizons School of Technology as a Co-Founder. Edward Lando attended the Wharton School.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
  • NewHomesMate (formerly Propertymate) — Find, compare and buy a new construction home - all in one place.
Pratima Aiyagari Angel · London, England, United Kingdom
Pratima is a Venture Partner at Nauta Capital and is based in London. At Nauta, Pratima focuses on enterprise software and deep tech domains.Pratima has 18+ years of professional experience. She is a software developer by background and spent several years in Silicon Valley working on developing intelligent network services in the networkmanagement domain. Pratima joins Nauta from US-based cybersecurity-focused investment firm Paladin Capital. Previously, Pratima led investments and acquisitions at Cisco Corporate Development in Europe with a specific focus on ML/AI, Enterprise Collaboration and Silicon. During her investment career, Pratima led an investment or held board seats in Aimotive, Adbrain, Evrythng, Secure Code Warrior, decentriq, Dashbird, and several fund investments. She also managed investments in several companies including Behaviosec, Italtel, ip.access, and Corvil.Pratima received her MBA from INSEAD in France and an MS in computer science from the Virginia Polytechnic Institute and State University in the US. Pratima is a co-author of a US patent in the area of network device clusters and high availability.
Show more
Investment focus
  • Analytics, Information Technology, Cyber Security
  • Pre-Seed, Seed, Series A
  • United Kingdom, France, Germany
Portfolio highlights
  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
  • ESPROFILER — ESProfiler is an enterprise platform that empowers CISOs to prioritise threats, optimise spend & continuously maximise return on investment
Ariel Poler Angel · San Francisco, California, United States
Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
Show more
Investment focus
  • Software, Social Media, Internet
  • Seed, Series A, Angel
  • United States, Mexico, United Kingdom
Portfolio highlights
  • Reloadly — Reloadly makes it easy for developers to connect with Mobile operator services. We are disrupting a Trillion dollar industry! Mobile Operators are stuck in old school business models, where most of the world is moving to open source platforms for developers to build amazing products. Reloadly is bridging the gap between mobile operators anddevelopers, and at the same time creating new sales channels for the 816 mobile operators around the world.
  • Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
  • humm — humm harnesses cutting-edge neuroscience into products that allow people to learn faster and perform better.humm is working to bring the incredible results of neuroscience research out of the lab and into non-invasive wearables that improve the quality of life for everyday people. Our first product is a clinically validated patch that you wearfor 15 minutes to get up to 90 minutes of improved working memory, by gently stimulating the signals in the part of the brain that controls your executive thinking. humm improves your ability to learn and be at your best, allowing people to reconnect with the joy of learning and challenge themselves to continue growing at any stage of life, whether it's for work or personal enjoyment!
Jon Oringer Angel · Miami, Florida, United States · 4 investments in the past 12 months
Jon Oringer is the founder and chairman of Shutterstock.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Pre-Seed, Funding Round
  • United States, France, United Kingdom
Portfolio highlights
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
  • Zamp — We give you freedom from sales tax! Eliminate the need to learn, manage or touch any part of the sales tax compliance process.
  • NewHomesMate (formerly Propertymate) — Find, compare and buy a new construction home - all in one place.
Patrick Pichette Angel · London, England, United Kingdom · 3 investments in the past 12 months
Patrick Pichette currently Board Member at LightSpeed and Twitter. He is a former Google's chief financial officer, where he started in June of 2008. He has nearly 20 years of experience in financial operations and management in the telecommunications sector, including seven years at Bell Canada, which he joined in 2001 as executive vicepresident of planning and performance management.During his time at Bell Canada, he held various executive positions, including CFO from 2002 until the end of 2003, and was instrumental in the management of the most extensive communications network in Canada and its ongoing migration to a new national IP-based infrastructure.Prior to joining Bell Canada, Patrick was a partner at McKinsey & Company, where he was a lead member of McKinsey's North American Telecom Practice. He also served as vice president and chief financial officer of Call-Net Enterprises, a Canadian telecommunications company.Patrick earned a bachelor's degree in business administration from UniversitA© du Quebec A  MontrA©al. He holds a master's degree in philosophy, politics, and economics from Oxford University, where he attended as a Rhodes Scholar. He also serves on the board of Engineers Without Borders (Canada).
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Seed, Series B, Series A
  • United Kingdom, Germany, United States
Portfolio highlights
  • Mobai — Provider of attack detection, image manipulation detection and authentication. Strong and successful research team on biometrics.
  • Apheris — Build ML-powered products using data that spans organizational or geographical boundaries, while ensuring compliance with regulation.
  • Unlikely AI — We are pioneering safe, trustworthy and powerful artificial intelligence
Ed Parkinson Angel
Ed Parkinson
Show more
Investment focus
  • Software, Health Care, Life Science
  • Seed
  • United Kingdom
Portfolio highlights
  • Antiverse — Designing biologics for 100 challenging targets
Nadav Ben-Chanoch Angel · Miami, Florida, United States · 6 investments in the past 12 months
Nadav Ben-Chanoch - Partner @ Pareto Holdings
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • Swaap — We build the market-neutral AMM protocol.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
Bradley Horowitz Angel · Palo Alto, California, United States · 4 investments in the past 12 months
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • United States, United Kingdom, Germany
Portfolio highlights
  • CUR8 — CUR8 is committed to establishing a global market for carbon reduction. Carbon removal methods include increased rock weathering, direct air capture, forests, construction, soil, biomass, oceans, and new technologies.
  • Mill — Meet the cleanest, easiest way to prevent food waste at home. Mill recycles your peels, bones, stalks, and forgotten leftovers.
  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
Jim Mellon Angel · 3 investments in the past 12 months
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more
Investment focus
  • Biotechnology, Health Care, Food and Beverage
  • Series A, Seed, Funding Round
  • United States, United Kingdom, Israel
Portfolio highlights
  • Amy — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
  • Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
  • The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Jon Oringer Angel · New York, New York, United States · 4 investments in the past 12 months
Jon Oringer is the founder and chairman of Shutterstock.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Series A
  • United States, France, United Kingdom
Portfolio highlights
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
  • Zamp — We give you freedom from sales tax! Eliminate the need to learn, manage or touch any part of the sales tax compliance process.
  • NewHomesMate (formerly Propertymate) — Find, compare and buy a new construction home - all in one place.
Chris Mairs Angel · London, England, United Kingdom · 3 investments in the past 12 months
Chris Mairs - Venture Partner @ Entrepreneur First
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Pre-Seed, Angel
  • United Kingdom, United States
Portfolio highlights
  • Quantly — LLM-enabled financial research at the speed of thought.
  • Statement — Find the right card machine for your business, with good rates and the best features. Search the top providers in minutes, including Worldpay, Barclaycard, Tyl and Teya.
  • Borderless — Borderless is a workforce migration platform.It offers automation solutions that focuses on all aspects of hiring and onboarding of foreign workers, including recruitment, immigration, relocation, and compliance.
Hugh Grant Angel · Saint Louis, Missouri, United States
Hugh Grant is President and Chief Executive Officer at Monsanto.
Show more
Investment focus
  • Biotechnology, Machine Learning
  • Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Nicholas Edwards Angel · Oxford, Oxfordshire, United Kingdom
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Paul Forster Angel · 4 investments in the past 12 months
Paul Forster
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Series A, Pre-Seed
  • United Kingdom, Germany, Spain
Portfolio highlights
  • Enzai — Enzai's AI governance platform allows you to build and deploy AI with confidence. Measure your progress in AI responsibility, and get actionable steps with our 3-minute maturity assessment.
  • Verisian — Verisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs)
  • Triple — The best payment data enrichment solution. Our API includes fraud detection, transaction enrichment, categorization, subscriptions, and carbon footprint.
Jon Oringer Angel · Miami, Florida, United States · 4 investments in the past 12 months
Jon Oringer is the founder and chairman of Shutterstock.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
  • Zamp — We give you freedom from sales tax! Eliminate the need to learn, manage or touch any part of the sales tax compliance process.
  • NewHomesMate (formerly Propertymate) — Find, compare and buy a new construction home - all in one place.
Sarah Howell Angel · London, England, United Kingdom · 2 investments in the past 12 months
Sarah Howell joined Arecor Limited as Chief Executive Officer in 2015.
Show more
Investment focus
  • Education, Health Care, Biotechnology
  • Funding Round, Post-IPO Equity
  • United Kingdom
Portfolio highlights
  • Arecor — Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.In addition toits internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Simon Galbraith Angel · Cambridge, Cambridgeshire, United Kingdom · 2 investments in the past 12 months
Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Pre-Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • BoobyBiome — BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. We aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk.
  • SysKit — SysKit is a software development company specializing in enterprise tools for SharePoint, Microsoft 365, Windows Server, Remote Desktop Services, Citrix.
Sharaf Yamani Angel · London, England, United Kingdom
Sharaf Yamani - Managing Director @ Windlesham Advisors
Show more
Investment focus
  • Biotechnology, Software, Life Science
  • Seed
  • India, United Kingdom
Portfolio highlights
  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Aydın Öztunalı Angel
Aydın Öztunalı
Show more
Investment focus
  • Software, Apps, Mobile
  • Seed, Angel
  • Turkey, United States, United Kingdom
Portfolio highlights
  • Evreka — Evreka is a leading SaaS company providing the most comprehensive intelligent solutions designed for the entire category of waste management across the globe.
  • Initio — initio is Enabling the transformation of the pharmaceutical industry today by using lab-on-a-chip and organ-on-a-chip technologies
  • Otsimo — Otsimo offers special education and speech therapy apps for autism, down syndrome and other developmental disabilities. Click to see our autism apps!
Hugo Amsellem Angel · Berlin, Berlin, Germany
Investing in consumer stuff (content, community, commerce, creators). Advisor at Jellysmack, previously Founding Team at The Family
Show more
Investment focus
  • Financial Services, FinTech, Software
  • Seed, Pre-Seed
  • United States, France, United Kingdom
Portfolio highlights
  • Figures — Figures delivers reliable, up-to-date salary and equity data, allowing the people professionals to plan and benchmark their compensation plan
  • Aria — TELL BEAUTIFUL STORIES
  • Intros AI — Intros is a developer of a communication platform to help people communicate within the community. Its platform also allows people to talk with each other through direct messaging or in interest groups and automate introductions between their members. Through this software, users feel more connected and supported while helping communities scaletheir personalized introductions.The company was founded in 2020 and is headquartered in Danvers, Massachusetts.
David Rowan Angel · London, England, United Kingdom · 2 investments in the past 12 months
David Rowan is editor of the UK edition of WIRED magazine, which won 2009 Launch of the David Rowan is Editor of the WIRED UK, the technology and trends magazine covering online brands, gadgets and the culture that surrounds them. David has reported on technology for The Times and Channel 4 News, the latter requiring him to illustrate the newiPod Video from the set of a porn shoot. He's also written for The Sunday Times and Telegraph Magazines, and edited the Guardian's on-line content. David has curated an exhibition of British creative talent at the Government's Cabinet Forum conference. He has also addressed the TEDs, and frequently contributes on Newsnight and the Today programme. He also writes a monthly column for GQ. David is in touch with many of the world's leading trend-setters and spotters. In presentations he looks at how the net is disrupting almost every sector, how apps change consumer behaviour and why 'social commerce' is killing traditional marketing. He reveals the 10 trends that will change your market in the next decade - and what you should be doing now to protect yourself.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Pre-Seed, Funding Round
  • United Kingdom, Germany, Croatia
Portfolio highlights
  • EWOR — Build a successful company with EWOR
  • Climate X — Climate X combines climate science and econometrics to deliver precise climate risk data without any black boxes.
  • Rhizocore Technologies — We develop high-performance strains of locally-sourced mycorrhizal fungi to improve tree growth, tree health and tree resiliency. We offer a sustainable solution to increase forest yields whilst improving the ability of trees to sequester carbon.
Andrew J M Richards Angel · 2 investments in the past 12 months
Andrew Richards is an established biotechnology entrepreneur and investor with extensive experience from the UK biotechnology sector in research, drug development, commercial deals and scale-up of companies.
Show more
Investment focus
  • Biopharma, Education, Biotechnology
  • Funding Round, Post-IPO Equity
  • United Kingdom
Portfolio highlights
  • Arecor — Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.In addition toits internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Declan Doogan Angel · Douglas, NA - Isle of Man, Isle of Man
Declan Doogan has over 30 years of industry experience in both major pharma and biotech.He was the Senior Vice-President and Head of Worldwide Development at Pfizer, where many multibillion dollar programs were delivered (e.g., Viagra, Lipitor and Zoloft). He has held a number of executive positions in Pfizer in the US, the UK and Japan. Sinceleaving Pfizer in 2007 he has been engaged in executive roles in small pharma. Declan was CMO and acting CEO of Amarin (AMRN: Nasdaq), transforming it from a failing Neuroscience company to a vibrant cardiovascular company with a market capitalization of over one billion dollars before his departure. He has also been Chief Medical Officer for Prometheus Laboratories, a molecular diagnostics company in San Diego. Declan is also an investor in emerging biotechnology and technology companies. He holds a number of Board appointments, principally in pharma companies, and has also held professorships positions at Harvard School of Public Health, Glasgow University Medical School and Kitasato University (Tokyo).Declan received his medical degree from Glasgow University in 1975. He is a Fellow of the Royal College of Physicians and the Faculty Pharmaceutical Medicine and holds a Doctorate of Science at the University of Kent in the UK.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Seed, Series A, Funding Round
  • United States, United Kingdom
Portfolio highlights
  • Causeway Therapeutics — A bio pharmaceutical spin out emerging from the University of Glasgow, working in the orthobiologic therapeutic space. Intellectual property has been generated via academic research demonstrating a proven mechanistic reasoning for the use of a microRNA therapy in the treatment of tendinopathies.
  • Intensity Therapeutics — Intensity is developing proprietary intratumoral immunotherapy products that both directly kill injected solid tumors AND induce immune system recognition of cancer cells throughout the body to address the three challenges of cancer treatment: local, regional, and metastatic disease.
Taz Patel Angel · San Francisco, California, United States
Taz Patel is a serial entrepreneur with multiple exits over the past decade who continues to support the startup ecosystem via mentorship, advisory and investing. Most recently, Taz co-founded Captiv8, an Influencer marketplace and SaaS platform funded by Social Capital, Liquid 2, Visionnaire, Jason Calacanis, Cyan Banister and strategic Angels.Before this, Taz was the Chief Revenue Officer of Republic Project, a startup funded by Google Ventures and later acquired by DG Sizmek in 2013. Before that, Taz led monetization efforts at Showyou App funded by True Ventures that was acquired by Vevo in 2015. His knowledge in social marketing, mobile/video advertising, and SaaS/Marketplace businesses is a personal passion that stems from early sales leadership roles at Interclick and BlueLithium, both of which were acquired by Yahoo! for $270 Million in 2011 and $300 Million in 2007. A Chicago native, Taz studied at the University of California, Berkeley and currently lives with his wife, son and dog in San Francisco.
Show more
Investment focus
  • SaaS, Information Technology, Mobile
  • Seed, Series A, Funding Round
  • United States, United Kingdom
Portfolio highlights
  • CloudAdmin.io — CloudAdmin is a cost-optimization platform that helps executives save money in hidden cloud instance buying options.
  • Ampleforth — Ampleforth is the name of a character in George Orwell's 1984 who is responsible for translating poetry into Newspeak, a language designed to limit freedom of thought. When tasked to replace the word “God” in a Kipling poem, Ampleforth refuses, not out of righteousness, or subversiveness, but rather, a simple love for language and respect forthe truth. To Ampleforth, no other word makes sense in context and therefore no other word should replace it.
  • Marigold Health — Marigold Health is an anonymous social network where people with mental health and substance use conditions support each other.
Jeff Dean Angel · Palo Alto, California, United States · 9 investments in the past 12 months
Jeff Dean joined Google in 1999 and is currently a Google Senior Fellow in Google's Research Group, where he leads the Google Brain team, Google's deep learning research team in Mountain View, working on systems for speech recognition, computer vision, language understanding, and various predictive tasks. He has co-designed /implemented five generations of Google's crawling, indexing, and query serving systems, and co-designed / implemented major pieces of Google's initial advertising and AdSense for Content systems. He is also a co­designer and co­implementor of Google's distributed computing infrastructure, including the MapReduce, BigTable and Spanner systems, protocol buffers, LevelDB, and TensorFlow, a popular open­-source system for machine learning.​Jeff received a Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the Mark Weiser Award and the ACM­-Infosys Foundation Award in the Computing Sciences.
Show more
Investment focus
  • Science/Engineering, Software, Data and Analytics
  • Seed, Series A, Series B
  • United States, United Kingdom
Portfolio highlights
  • Harvey — Harvey is an artificial intelligence technology service provider.
  • Parallel Bio — Parallel Bio uses human immune organoids to accelerate the discovery and development of treatments.
  • Juvena Therapeutics — Juvena Therapeutics is a venture-backed biopharma startup discovering novel protein-based therapeutics that promote tissue regeneration in the elderly and treat various age-related diseases.
Sami Mikati Angel
Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa.
Show more
Investment focus
  • Biotechnology, Software, Life Science
  • Seed
  • India, United Kingdom
Portfolio highlights
  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Ahmed Medhat Angel · San Francisco, California, United States
Ahmed Medhat - Research Scientist, Core Data Science @ Meta
Show more
Investment focus
  • Artificial Intelligence, Information Technology, Machine Learning
  • Seed, Pre-Seed
  • United States, United Kingdom
Portfolio highlights
  • Ntropy Network — Unlock the power of transactions. Our technology enables flexible and autonomous banking data cleansing, labeling and enhancement.
  • Grin Gaming — GrinData micro markets software leverages best-in-class high-frequency trading and machine learning to deliver reliable odds pricing on the most markets.
  • Anarchy — Anarchy builds a cloud platform for AI pioneers to build LLM tools augmented with external interactivity.
Silla Scheepens Angel
Silla Scheepens of Future Food Fund.
Show more
Investment focus
  • Biotechnology, Food Processing, Food and Beverage
  • Seed
  • United Kingdom
Portfolio highlights
  • Extracellular — Extracellular is a scale-up and development partner, channelling biology, digitalisation and biomanufacturing expertise to accelerate the potential of cultivated meat.
Martin Chavez Angel · New York, New York, United States · 2 investments in the past 12 months
Marty Chavez is executive vice president and chief financial officer of The Goldman Sachs Group, Inc. He is a member of the Management Committee, Firmwide Capital Committee, Firmwide Risk Committee and Steering Committee on Regulatory Reform. Marty is also a member of the Firmwide Hispanic/Latino Network and the Lesbian, Gay, Bisexual andTransgender Network.Marty first joined Goldman Sachs in 1993 in the J. Aron Currency and Commodities Division, where he was a senior energy strat until 1997. He returned to the firm as a managing director in Investment Banking Division Strats in 2005, becoming global co-head of Securities Division Strats and then global co-chief operating officer of the Equities Franchise. Prior to assuming his current role, Marty was chief information officer, responsible for the Technology Division and jointly responsible with divisional leadership for the firm’s global strategists. He was named partner in 2006.Prior to first joining the firm, Marty was co-founder and chief technology officer of Quorum Software Systems from 1989 to 1993. From 1997 to 2000, he was global head of energy derivatives at Credit Suisse Financial Products. In 2000, Marty co-founded Kiodex, Inc. and was chairman and chief executive officer until 2004.Marty serves on the Harvard Board of Overseers and is a Fellow of the New York Academy of Medicine.Marty earned a PhD in Medical Information Sciences from Stanford University in 1990, an SM in Computer Science from Harvard University in 1985, and an AB, magna cum laude, in Biochemical Sciences from Harvard College in 1985.
Show more
Investment focus
  • Health Care, Machine Learning, Biotechnology
  • Series A, Seed, Private Equity
  • United States, United Kingdom
Portfolio highlights
  • Hebbia — Hebbia's neural search lets you execute research 10X faster and 10X more accurately. Transform your productivity today.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • VMind AI — VMind is a frontier technology company building artificial general intelligence (AGI).
Alice Zhang Angel · San Francisco, California, United States · 2 investments in the past 12 months
CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Seed, Series A, Pre-Seed
  • United States
Portfolio highlights
  • Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
Huw Bishop Angel
Huw Bishop is an individual investor.
Show more
Investment focus
  • EdTech, Training, E-Learning
  • Angel
  • United Kingdom
Portfolio highlights
  • clear_pixel VR — We create virtual reality labs for practical neuroscience training which could lower your lab training time and budget by over 40%
Michelle Tempest Angel · 2 investments in the past 12 months
Michelle Tempest
Show more
Investment focus
  • Health Care, Science/Engineering, Gaming
  • Seed, Series A
  • United Kingdom
Portfolio highlights
  • Daye — Organic, super absorbent, sustainable tampons for when your period is cramping your style. ProViotics for vaginal health. We deliver sustainable products that work hard to help you feel your best, whatever life brings.
  • Medwise.ai — Medwise.ai is the Google for doctors.
Investors by industry
Investors by country
Angel Investors in United Kingdom by industry